{"id":"W4409374630","doi":"10.1016/j.jval.2025.03.010","title":"Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Pembrolizumab; Urothelial cancer; Oncology; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008392369,0.0001296656,0.0004123326,0.0002646796,0.00005327666,0.000006996164,0.00006958649,0.00003378828,0.00001037938],"category_scores_gemma":[0.0001135653,0.00008941838,0.00004200977,0.0004962421,0.00005841308,0.00002760024,0.00001502538,0.0001287423,3.084095e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002572285,"about_ca_system_score_gemma":0.0007291536,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04158888,"about_ca_topic_score_gemma":0.00146576,"domain_scores_codex":[0.998746,0.000297579,0.0003724098,0.0001970448,0.0001352223,0.000251692],"domain_scores_gemma":[0.9986999,0.0009534014,0.00008291785,0.0001569794,0.00005831286,0.00004847498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04907019,0.006131859,0.510269,0.06777154,0.001374902,0.0001230894,0.03489016,0.1558215,0.0004008049,0.02866272,0.001037343,0.1444469],"study_design_scores_gemma":[0.1126247,0.009063341,0.6932807,0.01397722,0.0007273903,0.00005526858,0.003395336,0.115057,0.005471745,0.02662606,0.0190912,0.0006300882],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864439,0.00333174,0.0009385025,0.003695071,0.0001708351,0.004953002,0.0003518971,0.00001439198,0.0001006935],"genre_scores_gemma":[0.9958851,0.002056194,0.0001436439,0.0009049252,0.00002293335,0.0008682154,0.00006497548,0.0000139325,0.00004008048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1830117,"threshold_uncertainty_score":0.9647933,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0888941128100231,"score_gpt":0.4019829747432881,"score_spread":0.313088861933265,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}